A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Recruiting · NCT07071090 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors | Solid Tumor Malignancies | Recruiting | Phase 1 | 2026-09-16 | NCT07071090 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Heronova Pharmaceuticals | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Cancer Hospital | Fuzhou | China | 55 |
| Guangxi Medical University Cancer Hospital | Nanning | China | 24 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Hunan Cancer Hospital | Changsha | China | 87 |
| Shandong Cancer Hospital | Jinan | China | 31 |
| Sir Run Run Shaw Hospital | Hangzhou | China | 7 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 113 |